Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Islet Transplantation Into the Gastric Submucosa for Type 1 Diabetes
NCT02402439Phase 1Completed
- Start
- Mar 2016
- Primary completion
- Apr 2019
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of islet cells in type 1 diabetes mellitus (T1D). Primary endpoint: Insulin independence at 1 year. Started Mar 2016; status: completed.
02
Drugs
islet cells
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02402439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02402439.